Patentable Innovative Research Ayoade MJ. Oduola University of Ibadan Research Foundation University of Ibadan 11 August 2015 College of medicine Workshop.

Slides:



Advertisements
Similar presentations
1 AID FOR TRADE IN AFRICA: Why Trade? Why AID? MOBILIZING AID FOR TRADE: FOCUS ON AFRICA Dar es Salaam, Tanzania John Page, Chief Economist Africa Region,
Advertisements

AfDB Partnership Forum March 2010 HIGHER EDUCATION SCIENCE AND TECHNOLOGY TRUST FUND Presenter: Baboucarr Sarr Human Development Department.
Exporting For Growth Brian Cooper International Trade Adviser Advanced Engineering
Global Dynamism Index (GDI) 2013 summary report Model developed by the Economist Intelligence Unit (EIU)
Economic Growth and Globalization since 1850
 The United States continues to remain the world’s largest economy, according to the World Bank ranking that measures 214 economies based on their.
1 BRICS, A NEW GLOBAL PLAYER IN THE MAKING. BRICS MEANS …… 25% of the world GDP (measured in PPP of national currencies) 30% of the Earth’s territory.
How Economies Grow and Develop
CHAPTER 2.4 Gross Domestic Product. Most economists view the country like one big business They measure the success of this business through gross domestic.
Figure 14.1 Economic Growth in the ADE/ASR model.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
The Idea of “East Asian Economic Community” from Business Perspective
The Global Economic Environment
Author: Dr Sc Fidel Castro Díaz - Balart World Science Forum Budapest November 2005 Knowledge and Innovation: Challenges and uncertainties for the South.
Copyright ©2001, South-Western College Publishing Contemporary Economics: An Applications Approach By Robert J. Carbaugh 1st Edition Chapter 10: Gross.
The stakes of Development: from development to sustainable development.
Robert Wells Head, Biotechnology Unit Oslo, Norway 11 October Life Sciences for Health and Innovation: An OECD Perspective.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
Indonesia - The World’s Next Economic Power Chairul Tanjung Chairman of National Economic Committee (KEN) KOMITE EKONOMI NASIONAL REPUBLIK INDONESIA July.
Growth & Less Developed Countries The International Economy.
Environmental Problems, Their Causes and Sustainability.
ATTRACTING PUBLIC AND PRIVATE SECTOR FUNDING TO SUPPORT SCIENCE AND TECHNOLOGY CENTERS OF EXCELLENCE IN AFRICA Presented by: Karl S. Wright, Ph.D., President.
Director, DG RTD, Directorate International Cooperation
DIGEST OF KEY SCIENCE AND ENGINEERING INDICATORS 2008 Presentation Slides National Science Board.
Sir David King Chief Scientific Adviser to UK Government UK and South Africa: Working in Partnership Cape Town 18 May 2005.
Technology and innovation management in Israel Isaure MAIZA Sandra EDERY GBEM_ 16/10/2007.
Global Economic Environment. World Population Top In Millions China: 1,208 India: 939 Rest of World: 2,397 Pakistan: 131 Indonesia: 194 Brazil:
1 THE ROLE OF SCIENCE AND TECHNOLOGY IN THE EMERGING AFRICAN UNIVERSITY Sibry TAPSOBA (Ph.D) Manager – Education, Science and Technology Division African.
Investing in the State of Innovation International Seminar on Knowledge and Innovation 1 October, 2013 Creating a High-Performance Innovation Ecosystem:
Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.
Innovation and Competence Building systems in Russia Brics-workshop, Aalborg, February 12–15, 2006.
INFSO-RI Enabling Grids for E-sciencE V. Breton, 30/08/05, seminar at SERONO Grid added value to fight malaria Vincent Breton EGEE.
9. Fundamental Concepts of Macroeconomics 1.Objectives and Methods of Macroeconomics 2.Economic Growth 3.National Accounting.
The Global Economic Environment The Coming Boom Wealthy Industrial Countries Developing Countries East Asia South Asia Latin America
Unprecedented Growth Opportunity BIOTECHNOLOGY. Biotechnology  India - An Overview  Market and Growth Potential  Players  Opportunities  Why India?
1 U.S. Science & Technology: Issues and Outlook by Erich Bloch Director September 26, 2005.
Consortium for Interdisciplinary Studies on Science for Aging.
Indian Innovation Capabilities in the Context of 'Make in India': A Global comparative scenario Workshop on “STI for ‘Make in India” at India International.
Kiichiro Fukasaku Development Centre
SAUDI ARABIA THE BUSINESS GATEWAY TO THE MIDDLE EAST October 2015
2015 World Bio Summit and Expo Dubai, UAE Dr. Mark G. Bloom, CLP, RTTP Registered U.S. Patent Attorney Keynote Presentation 1.
Centre for Policy Alternatives, New Delhi
2012/13 Annual Report Presentation to the Portfolio Committee on Science and Technology 1 MR THULANI MAVUSO ACTING CEO 08 OCTOBER 2013.
Laurie E. Locascio, Ph.D. Director, MML/NIST NIST/MML: Measurement Assurance for Biological Systems.
1. BIOPHARMACEUTICAL Korea Where Success Knows No Limits 2 Index 1. Industry Overview3 2. Competitive Standing and Outlook9 3. Government Policies14 4.
Unprecedented Growth & Future Job Opportunity BIOTECHNOLOGY Dr. Sanjiv Kumar Maheshwari Professor and Dean, IFTM University, Moradabad.
Internationalisation Strategy Refresh Baseline data analysis Research Team Spring 2016.
Sustainable Development in cities in India Dr. Shaleen Singhal Head, Department of Policy Studies Sustainable Cities and Interdisciplinary International.
MINISTRY OF TRADE AND INDUSTRY SINGAPORE’S ECONOMIC PLANNING.
6. Ráðstefnan um rannsóknir á íslensku þjóðfélagi Háskólanum á Akureyri, 20. – 21. apríl 2012 The Nordic Countries in an International Comparison Helga.
Kazakhstan Economic Policy 1. Contents 1Country overview 2Diversification policy of Kazakhstan 3Initiatives in Kazakhstan 4Anti crisis initiatives 5New.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Digital Genome Market share accounted for over 80% of the North American revenue in 2015.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Mammalian Cells Bioreactor Market to reach $1.5 bn by 2024
Manufacturing in Nigeria: Opportunities for Investment
Global Manufacturing – India
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Address to the IEEE Region 10 Leadership IEEE Region 10 Meeting
Sino-Indian Energy Cooperation in the 21st Century
Synthetic Biology Market Global synthetic biology market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast.
Databridgemarketresearch.comdatabridgemarketresearch.com US : UK :
Sangers Sequencing Service Market is Witnessing High Growth by 2025
Bioinformatics Market Drivers, Restraints, Opportunities, Trends, and Forecasts to 2025
NEW KNOWLEDGE, TECHNOLOGY AND INNOVATION
FMA 601 Foreign Market Analysis
(Billions of U.S. Dollars)
Overview of the development of Life Sciences in ASEAN and relevance of biosecurity awareness.
Improving Standards in Packaging & Access to Equipment
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
NATIONAL HUMAN CAPITAL FOR SCIENCE, ENGINEERING AND TECHNOLOGY PLAN
GLOBAL TRANSPLANT DIAGNOSTICS MARKET 2017 – 2025 Published by :Accurize Market Research Pvt. Ltd. Copyright © 2019 Accurize Market Research
Presentation transcript:

Patentable Innovative Research Ayoade MJ. Oduola University of Ibadan Research Foundation University of Ibadan 11 August 2015 College of medicine Workshop

This Session Presentation 30 minutes Discussions10 minutes Suggestions on way forward

Outline of presentation Why Patent and Innovations? Africa - Economic Statistics Human Genome Sequencing (a landmark in S&T) India Biotechnology Industry–Context of sustainable development Product Areas and Dividends of Biotechnology Example of research areas

Africa Population 1.1 Billion (15% World Population) GDP US$ 2,390 Trillion (2013) GDP Growth 5.16% ( )* GDP Per Capital US$ 2,320 Millionaires 100,000 (1%) People living in poverty <US$1 per day 36.2% Low population Density but growing at an alarming rate. 65 people per square mile

Global Economic Ranking Rank Country (Rank) GDP(Millions US $) IMF 2013 GDP(Millions US $) World Bank US 16,799,70016,800,000 2 China 9,181,377 (n-2) 9,240,270 (n-2) 3 Japan 4,901,5324,901,530 4 Germany 3,635,9593,634,823 7 Brazil 2,242,8542,245, India 1,870,6511,876, Thailand 387,156387, South Africa 350,779350,630 38/23 Nigeria 286,470 ( 38)522,638 (23) "World Economic Outlook""World Economic Outlook". IMF. April 2013 data. National Bureau of Economic Research2014.National Bureau of Economic Research

Global Economic Ranking Rank Country (Rank) GDP(Millions US $) IMF 2013 GDP(Millions US $) World Bank US 16,799,70016,800,000 2 China 9,181,377 (n-2) 9,240,270 (n-2) 3 Japan 4,901,5324,901,530 4 Germany 3,635,9593,634,823 7 Brazil 2,242,8542,245, India 1,870,6511,876, Thailand 387,156387, South Africa 350,779350,630 38/23 Nigeria 286,470 ( 38)522,638 (23) "World Economic Outlook""World Economic Outlook". IMF. April 2013 data. National Bureau of Economic Research2014.National Bureau of Economic Research

The Night

BRICS CountryPopulation GDP (nominal) Literacy rateLiteracy rate Life expectancy Life expectancy (years, avg.) South AfricaSouth Africa 51,770,560$350.8 bn93% [38] [38] 51.2 Russia 143,451,702$2,118.0 bn99.6%70.7 Brazil 201,046,886$2,242.8 bn93.5%74.6 India 1,210,193,422$1,870.6 bn74.04%64.2 China 1,354,040,000$9,181.4 bn95.1% [37] [37] 72.7

BRICS Country GDP per capita (PPP) Governmen t spending ExportsImports South AfricaSouth Africa $11,375$95.27 bn$101.2 bn$106.8 bn Russia $17,708$414.0 bn$542.5 bn$358.1 bn Brazil $13,623$846.6 bn$256.0 bn$238.8 bn India $3,829$281.0 bn$309.1 bn$500.3 bn China $9,161$2,031.0 bn$2,021.0 bn$1,780.0 bn

Promises to All?

Brazil: Leadership in Genomics and Biotechnology in Developing World

INDIA

India: Biotechnology Indian bio-economy 2003USD 530 Million Indian bio-economy 2013 USD 4.3 Billion 30% Growth per year USD 100 billion 2025 Market’s revenues USD 3.31 Billion Market’s Size–13USD 4.3 Billion 28 % Growth in 2013–17 USD 11.6 Billion

India: Key Opportunity Segments Vaccines Bio-Pharma R&D Agri Biotech Therapeutics Bio Services Industrial Biotech Diagnostics Bioinformatics Bio Suppliers

Biotechnology: Key Opportunity Segments Vaccines Bio-Pharma R&D Agri Biotech Therapeutics Bio Services Industrial Biotech Diagnostics Bioinformatics Bio Suppliers

Sequencing bacterial and parasitic pathogens... could buy the sequence of every virulence determinant, every protein antigen and every drug target… for all time. B.R. Bloom (1995) Nature 378, 236 From Genomes to Discovery Gene Structure and function Drugs Vaccines Diagnostics

Comparative database mining Comparative biochemistry & molecular biology Genome Proteome Validated targets MetabolomeTranscriptome DNARNAProtein Metabolites & Macromolecules Target Discovery & Validation Potential targets Genetic validation (essentiality) Chemical validation (selectivity) (added value)

Access to international genomic research resources BROAD Institute, SANGER Institute, National Institutes of Health (NIH) Site 1Site 2 Site 3 Site 4 Population Studies Assay Development based on use Population genomics Epidemiological research (4 sites) Identification of drug resistant loci Proteomics (parasite protein & genome) Deployment strategy Assays for parasites in patients Vector population & ITNs Vector modelling Design intervention strategy Development of non-invasive diagnostics (RDTs) Monitoring of insecticide resistance in vectors parasitesvectorspeople Monitoring parasite popul. for drug resistance Current Advances in Basic, Genomic and Clinical Research Assays for markers in parasites Assays for insecticide resistance Entomology Enhance & scale up home, near home management of malaria Monitor impact of depletion of population on malaria transmission Leveraging Genomic and Population Data to Develop Molecular Diagnostic and Surveillance Tools for Home Management of Malaria Evaluation & validation

Makler et. Al Parasitology Today. 14:9,

parasitesvectors Strategic, Pragmatic and Effective Home management of Malaria ITN, Iptp, Ipti people Research Centres Testing Centres All Centres Capacity building Post docs, PHDs, Tech and infrastructure MD1 Vector Control InsecticidesVector population Malaria transmission Mosquito population Dynamics Experimental Design Field Evaluation Strategy to use ITNs Deployment Strategy Model MD2 Administrative & Data Cores Access to international genomic research resources BROAD Institute, SANGER Institute, National Institutes of Health (NIH) Non Invasive Diagnostics Proteomics Proteins Evaluation & Validation Genome Validation Deployment Strategy Assay Development Diagnostics parasitespeople Leverage advances in genomics, clinical & basic research and population genetics for public health through:

The Night

Spending on Science & Technology AU in 2007 –recommended 1 per cent of GDP to research and development by 2020 Sub-Saharan African countries spent on average 0.3% North African countries spend a comparative 0.4% South Africa spends 0.87% of GDP on science and technology research.

Source: AFRICAN INNOVATION OUTLOOK II/OECD

The economy of Africa consists of the trade, industry, agriculture, and human resources of the continent

The University of Ibadan: Measures of Academic Excellence I Student Population20,000 Academic Staff Strength1400 Number of students graduated187,255 Number of Publications Per year300 InfrastructureFair/Good Contributions to National Development Commendable

World Competitiveness Yearbook 2010 The World Competitiveness Yearbook measures 58 countries on the basis of 327 criteria. The International Institute for Management Development reports that Singapore, Hong Kong and the US come out on top in the World Competitiveness Rankings, while South Africa improved its position to 44th place.International Institute for Management Development The Economist

Domac, Richards and Risovics, Biomas and Bioenergy 28: Why Invest in Energy Research?